Megestrol Acetate Patent Expiration

Megestrol Acetate is Used for treating anorexia, cachexia, or unexplained significant weight loss in AIDS patients. It was first introduced by Bristol Myers Squibb in its drug Megace on Approved Prior to Jan 1, 1982. Another drug containing Megestrol Acetate is Megace Es. 12 different companies have introduced drugs containing Megestrol Acetate.


Megestrol Acetate Patents

Given below is the list of patents protecting Megestrol Acetate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Megace Es US6592903 Nanoparticulate dispersions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate Sep 21, 2020

(Expired)

Endo Operations
Megace Es US7101576 Nanoparticulate megestrol formulations Apr 22, 2024

(Expired)

Endo Operations
Megace Es US9040088 Nanoparticulate megestrol formulations Apr 22, 2024

(Expired)

Endo Operations
Megace Es US9101540 Nanoparticulate megestrol formulations Apr 22, 2024

(Expired)

Endo Operations
Megace Es US9101549 Nanoparticulate megestrol formulations Apr 22, 2024

(Expired)

Endo Operations
Megace Es US9107827 Nanoparticulate megestrol formulations Apr 22, 2024

(Expired)

Endo Operations


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Megestrol Acetate Generics

Several generic applications have been filed for Megestrol Acetate. The first generic version for Megestrol Acetate was by Usl Pharma Inc and was approved on Oct 2, 1987. And the latest generic version is by Chartwell Life Molecules Llc and was approved on Dec 1, 2017.

Given below is the list of companies who have filed for Megestrol Acetate generic.


1. XTTRIUM LABS INC

Xttrium Laboratories Inc has filed for 1 generic for Megestrol Acetate. Given below are the details of the strengths of this generic introduced by Xttrium Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
40MG/ML suspension Discontinued ORAL N/A Nov 1, 2004


2. TWI PHARMS

Twi Pharmaceuticals Inc has filed for 1 generic for Megestrol Acetate. Given below are the details of the strengths of this generic introduced by Twi Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
125MG/ML suspension Prescription ORAL AB Aug 27, 2014


3. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Megestrol Acetate. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
20MG tablet Discontinued ORAL N/A Sep 29, 1995
40MG tablet Discontinued ORAL N/A Sep 29, 1995
40MG/ML suspension Discontinued ORAL N/A Jun 9, 2017


4. TEVA PHARMS

Teva Pharmaceuticals Usa has filed for 1 generic for Megestrol Acetate. Given below are the details of the strengths of this generic introduced by Teva Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
40MG/ML suspension Discontinued ORAL N/A May 5, 2003


5. BARR

Barr Laboratories Inc has filed for 2 different strengths of generic version for Megestrol Acetate. Given below are the details of the strengths of this generic introduced by Barr.

Strength Dosage Form Availability Application Pathway TE code Launch Date
40MG tablet Prescription ORAL AB Nov 30, 1995
20MG tablet Prescription ORAL AB Aug 16, 1996


6. TEVA

Teva Pharmaceuticals Usa Inc has filed for 1 generic for Megestrol Acetate. Given below are the details of the strengths of this generic introduced by Teva.

Strength Dosage Form Availability Application Pathway TE code Launch Date
40MG tablet Discontinued ORAL N/A Feb 27, 1998


7. STRIDES PHARMA

Strides Pharma Global Pte Ltd has filed for 3 different strengths of generic version for Megestrol Acetate. Given below are the details of the strengths of this generic introduced by Strides Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
40MG

(reference standard)

tablet Prescription ORAL AB Aug 8, 1988
20MG tablet Prescription ORAL AB Aug 8, 1988
40MG/ML

(reference standard)

suspension Prescription ORAL AB Jul 25, 2001


8. USL PHARMA

Usl Pharma Inc has filed for 2 different strengths of generic version for Megestrol Acetate. Given below are the details of the strengths of this generic introduced by Usl Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
20MG tablet Discontinued ORAL N/A Oct 2, 1987
40MG tablet Discontinued ORAL N/A Oct 2, 1987


9. CHARTWELL

Chartwell Life Molecules Llc has filed for 1 generic for Megestrol Acetate. Given below are the details of the strengths of this generic introduced by Chartwell.

Strength Dosage Form Availability Application Pathway TE code Launch Date
125MG/ML suspension Discontinued ORAL N/A Dec 1, 2017


10. NOVITIUM PHARMA

Novitium Pharma Llc has filed for 1 generic for Megestrol Acetate. Given below are the details of the strengths of this generic introduced by Novitium Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
40MG/ML suspension Prescription ORAL AB Feb 16, 2006